澳大利亚肾脏病的可预防生产力负担
BACKGROUND: Kidney disease is associated with impaired work productivity. However, the collective effect of missed work days, reduced output at work, and early withdrawal from the workforce is rarely considered in health-economic evaluations.…
要点
- 研究提示应投资预防措施以减少未来肾脏病病例。
核心结论
- 在澳大利亚追求相对温和的肾脏病预防目标即可延长生命年并增加生产性生命年,带来显著经济效益。
研究设计与样本
- 构建澳大利亚工作年龄人群(15-69岁)10年(2020-2029)动态生命表模型,按肾脏病状态分层,数据来自文献。
主要发现
- 预测2020至2029年新发肾脏病病例将超过161,000例。
- 预防10%新发病例可避免超过300例过早死亡,节省约550年生命和7600 PALY。
关键数值与推荐
- PALY以每等效全职工人GDP进行货币化估值。
- 结局按每年5%贴现。
临床怎么用
- 临床与公共卫生决策中可将PALY纳入肾脏病预防措施的经济学评估。
- 提示应加强肾脏病预防投入以降低未来疾病负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kidney disease is associated with impaired work productivity. However, the collective effect of missed work days, reduced output at work, and early withdrawal from the workforce is rarely considered in health-economic evaluations. METHODS: To determine the effect on work productivity of preventing incident cases of kidney disease, using the novel measure "productivity-adjusted life year" (PALY), we constructed a dynamic life table model for the Australian working-age population (aged 15-69 years) over 10 years (2020-2029), stratified by kidney-disease status. Input data, including productivity estimates, were sourced from the literature. We ascribed a financial value to the PALY metric in terms of gross domestic product (GDP) per equivalent full-time worker and assessed the total number of years lived, total PALYs, and broader economic costs (GDP per PALY). We repeated the model simulation, assuming a reduced kidney-disease incidence; the differences reflected the effects of preventing new kidney-disease cases. Outcomes were discounted by 5% annually. RESULTS: Our projections indicate that, from 2020 to 2029, the estimated number of new kidney-disease cases will exceed 161,000. Preventing 10% of new cases of kidney disease during this period would result in >300 premature deaths averted and approximately 550 years of life and 7600 PALYs saved-equivalent to a savings of US$1.1 billion in GDP or US$67,000 per new case avoided. CONCLUSIONS: Pursuing a relatively modest target for preventing kidney disease in Australia may prolong years of life lived and increase productive life years, resulting in substantial economic benefit. Our findings highlight the need for investment in preventive measures to reduce future cases of kidney disease.
引用
- Savira F, Ademi Z, Wang BH, et al. The Preventable Productivity Burden of Kidney Disease in Australia. J Am Soc Nephrol. 2021. PMID: 33687979. doi:10.1681/ASN.2020081148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。